Gene therapy trial hopes to ease Parkinson's symptoms
NCT ID NCT05822739
First seen Jan 18, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This early-stage study tested a gene therapy called BBM-P002 in 10 people with advanced Parkinson's disease. The main goal was to see if the treatment is safe and tolerable. Researchers also looked at whether it could improve symptoms and reduce the need for daily Parkinson's medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.